Tirzepatide CAS NO.2023788-19-2

Tirzepatide,  is a medication used for the treatment of type 2 diabetes.

Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are hormones involved in blood sugar control.  After a person has eaten, these hormones are secreted by cells of the intestines and in turn cause the secretion of insulin. Tirzepatide is a GIP-analogue which activates both the GLP-1 and GIP receptors, leading to improved blood sugar control..

Tirzepatide is a glucose-dependent insulin-stimulating peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor dual agonist that integrates the two insulin-stimulating effects into a single molecule. Through a dual mechanism of action to activate the hormone receptors involved in blood glucose control -GIP and GLP-1 two incretin receptors.

Our advantage：

• Leading peptide manufacturer in China
• High Technology Enterprise Award
• GMP standard workshop
• High purity peptide
• Competitive price and excellent service
• Shorter production cycle